Dr. Susan Carnell and her team are researching ways to treat or prevent obesity more effectively.
Child and Adolescent Psychiatry
Substance Use Disorder
Mouse Studies Advance Search for New Class of Antidepressants
Released: February 7, 2019. In experiments with mice, researchers at Johns Hopkins Medicine report a promising advance in the search for a new class of drugs to treat major depression.
A compound developed by the Johns Hopkins Drug Discovery Group targets a chemical in specific cells of the mammalian brain, and eases signs of social avoidance and depression in rodents, without some of the toxic side effects that have bedeviled its parent compound.
#TomorrowsDiscoveries: Preventing Obesity
Seeking Knowledge to Cure and Prevent
Our clinical research programs range from efficacy and treatment-response studies to clinical trials and epidemiology. Our basic research encompasses bioinformatics, genetics, neuroscience, neuroimaging, and molecular biology - all in an effort to unlock the causal pathways to the major psychiatric conditions and to use this knowledge to develop practical means to improve diagnosis and treatment.
The depth of our clinical expertise and the breadth of our research programs allow us to train the next generation of psychiatrists and scientists to be clinical and research leaders. Our educational programs include medical student education, a general psychiatry residency, a child and adolescent psychiatry residency, and post-doctoral fellowship and research training opportunities.Training Programs